regulatory
confidence high
sentiment negative
materiality 0.70
XWELL (XWEL) receives Nasdaq minimum bid price deficiency notice; cure period to Nov 10, 2025
XWELL, Inc.
- Nasdaq notified XWELL on May 13, 2025 that its common stock's closing bid price was below $1.00 for 30 consecutive business days (Mar 31 - May 12, 2025).
- Company has 180 calendar days, until November 10, 2025, to regain compliance by maintaining a $1.00 closing bid for at least ten consecutive business days.
- If not compliant by Nov 10, XWELL may qualify for an additional 180-day period if it meets all other Nasdaq Capital Market initial listing standards.
- There can be no assurance of eligibility for an additional cure period or that Nasdaq will grant continued listing if delisting proceedings begin.
- The notice has no immediate impact on listing; XWELL's common stock continues to trade on Nasdaq pending compliance with other requirements.